Mexate side effects, by duration, gender and age (a phase IV clinical study of FDA data)

female:

1. Alanine aminotransferase increased
2. Abdominal pain upper
3. Acne (skin problems that cause pimples)
4. Fatigue (feeling of tiredness)
5. Abnormal faeces (abnormal stool)
6. Alveolitis fibrosing (idiopathic pulmonary fibrosis)
7. Bone amp joint tuberculosis
8. Cystitis haemorrhagic (blood in the urine and painful voiding)
9. Drug hypersensitivity
10. Drug maladministration

male:

1. Abscess intestinal (collections of pus-intestinal)
2. Biopsy lymph gland abnormal
3. Surgery
4. Blood creatinine decreased
5. Blood culture positive
6. Blood glucose increased
7. Chest pain
8. Dehydration (dryness resulting from the removal of water)
9. Diabetes mellitus inadequate control
10. Hodgkin's disease mixed cellularity recurrent (cancer originating from white blood cells)

0-1:

n/a

2-9:

1. Alanine aminotransferase increased

10-19:

n/a

20-29:

1. Blood culture positive
2. Cystitis haemorrhagic (blood in the urine and painful voiding)
3. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)

30-39:

1. Alanine aminotransferase increased
2. Abnormal faeces (abnormal stool)
3. Injection site erythema (redness at injection site)

40-49:

1. Abdominal pain upper
2. Biopsy lymph gland abnormal

50-59:

1. Bone amp joint tuberculosis
2. Drug toxicity
3. Gallbladder disorder
4. Hodgkin's disease nodular sclerosis stage unspecified (cancer originating from white blood cells -unspecified)
5. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
6. Surgery

60+:

1. Abscess intestinal (collections of pus-intestinal)
2. Blood creatinine decreased
3. Chest pain
4. Drug hypersensitivity
5. Hodgkin's disease mixed cellularity recurrent (cancer originating from white blood cells)
6. Lentigo (a small pigmented spot on the skin with a clearly-defined edge, surrounded by normal-appearing skin)

< 1 month:

n/a

1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

1. Drug toxicity

5 - 10 years:

n/a

10+ years:

n/a

not specified:

1. Alanine aminotransferase increased
2. Blood culture positive
3. Blood glucose increased
4. Bone amp joint tuberculosis
5. Chest pain
6. Cystitis haemorrhagic (blood in the urine and painful voiding)
7. Dehydration (dryness resulting from the removal of water)
8. Diabetes mellitus inadequate control
9. Drug hypersensitivity
10. Drug maladministration